| NCT00304954 | National Eye Institute (NEI) | Age-Related Macular Degeneration|Choroidal Neovascularization | 2006-02 | PHASE2 |
| NCT00019227 | National Cancer Institute (NCI) | Lymphoma|Radiation Toxicity | 1996-10 | PHASE1|PHASE2 |
| NCT00100178 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|National Institute of Allergy and Infectious Diseases (NIAID)|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Juvenile Diabetes Research Foundation|National Center for Research Resources (NCRR) | Diabetes Mellitus, Type 1 | 2004-05 | PHASE2 |
| NCT00626015 | John Sampson|National Cancer Institute (NCI) | Malignant Neoplasms of Brain | 2007-03 | PHASE1 |
| NCT02554955 | Hoffmann-La Roche | Heart Transplantation | 2004-02 | PHASE4 |
| NCT01172418 | University of Miami | Transplant; Failure, Kidney | 2006-02 | PHASE4 |
| NCT00001941 | National Cancer Institute (NCI) | HTLV-I Infection|T Cell Leukemia | 1999-12 | PHASE1|PHASE2 |
| NCT00048165 | Hoffmann-La Roche | Heart Transplantation | 1999-08 | PHASE4 |
| NCT00050661 | Rockefeller University|Facet Biotech | Psoriasis | 1997-10 | PHASE1|PHASE2 |
| NCT01064401 | Biogen|AbbVie | Relapsing-Remitting Multiple Sclerosis | 2010-05 | PHASE3 |
| NCT00001526 | National Eye Institute (NEI) | Uveitis | 1996-06-04 | PHASE1 |
| NCT01462318 | Biogen | Relapsing-Remitting Multiple Sclerosis | 2011-11 | PHASE3 |
| NCT01046955 | University of Miami|Hoffmann-La Roche | End-Stage Renal Disease|Living Donors | 2005-11 | PHASE4 |
| NCT00203281 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Kidney Transplantation|Plasmapheresis | 2003-02 | |
| NCT01051349 | Biogen|AbbVie | Relapsing-Remitting Multiple Sclerosis | 2010-03-31 | PHASE2 |
| NCT00195273 | Wyeth is now a wholly owned subsidiary of Pfizer | Graft vs Host Disease|Kidney Transplantation | 2004-11 | PHASE3 |
| NCT00014911 | National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN) | Diabetes Mellitus, Insulin-Dependent | 2001-04 | PHASE2 |
| NCT01797965 | Biogen|AbbVie | Relapsing-Remitting Multiple Sclerosis|Multiple Sclerosis | 2013-02-15 | PHASE3 |
| NCT00073047 | Facet Biotech | Ulcerative Colitis|Gastrointestinal Disease|Inflammatory Bowel Disease | 2003-04 | PHASE2 |
| NCT02686619 | Hoffmann-La Roche | Renal Transplantation | 2004-11 | PHASE3 |
| NCT00071838 | National Institute of Neurological Disorders and Stroke (NINDS) | Multiple Sclerosis, Relapsing-Remitting | 2003-10-30 | PHASE2 |
| NCT00023231 | National Institute of Allergy and Infectious Diseases (NIAID) | End-Stage Renal Disease | 2001-02 | NA |
| NCT00002681 | Roger Williams Medical Center|National Cancer Institute (NCI)|Beth Israel Deaconess Medical Center | Leukemia|Lymphoma | 1995-07 | PHASE1|PHASE2 |
| NCT00446264 | University Hospital, Lille|Institut National de la Santé Et de la Recherche Médicale, France | Type 1 Diabetes|Hypoglycemia|Metabolic Diseases | 2003-05 | PHASE2 |
| NCT00028288 | Facet Biotech | Asthma | 2001-09 | PHASE2 |
| NCT00040248 | National Institute of Allergy and Infectious Diseases (NIAID) | Wegener´s Granulomatosis | 2002-06 | PHASE2 |
| NCT00790439 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Diabetes Mellitus, Type I | 2008-07 | PHASE2 |
| NCT00284531 | Baylor College of Medicine|Roche Pharma AG | Cardiac Transplantation | 2003-10 | PHASE1|PHASE2 |
| NCT00275509 | Johns Hopkins University | Kidney Failure, Chronic | 2007-01 | PHASE3 |
| NCT00434850 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Diabetes Mellitus, Type 1 | 2006-10 | PHASE2 |
| NCT00574470 | University of Iowa | Graft vs Host Disease | 2006-01 | PHASE4 |
| NCT00363116 | University of Cincinnati|Roche Pharma AG|University of Tennessee | Acute Allograft Rejection in Simultaneous Kidney+Pancreas Transplant Recipients | 1999-04 | PHASE4 |
| NCT00043667 | National Eye Institute (NEI) | Uveitis | 2002-08 | PHASE2 |
| NCT02881567 | Biogen|AbbVie | Relapsing-Remitting Multiple Sclerosis (RRMS) | 2017-04-18 | PHASE3 |
| NCT00493194 | University Hospital, Antwerp|Wyeth is now a wholly owned subsidiary of Pfizer|Hoffmann-La Roche | Kidney Failure, Chronic|Transplantation|Immunosuppression|Interstitial Fibrosis | 2005-05 | PHASE4 |
| NCT00109161 | PDL BioPharma, Inc. | Multiple Sclerosis | 2005-04 | PHASE2 |
| NCT00050648 | Rockefeller University|Facet Biotech | Psoriasis | 1997-10 | PHASE1|PHASE2 |
| NCT00468442 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Type 1 Diabetes Mellitus | 2006-11 | PHASE2 |
| NCT00006350 | University of Maryland, Baltimore | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 2000-01 | PHASE2 |
| NCT00130637 | National Eye Institute (NEI)|The Emmes Company, LLC | Anterior Uveitis|Arthritis, Juvenile Idiopathic|Iritis|Immunosuppression | 2005-08 | PHASE2 |
| NCT00468117 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Type 1 Diabetes Mellitus | 2007-01 | PHASE3 |
| NCT00296348 | Astellas Pharma Inc | Kidney Transplantation | 2005-11 | PHASE3 |
| NCT00847106 | Radboud University Medical Center|Dutch Cancer Society | Melanoma | 2004-03 | PHASE1|PHASE2 |
| NCT00001962 | National Heart, Lung, and Blood Institute (NHLBI) | Aplastic Anemia|Pure Red Cell Aplasia|Diamond Blackfan Anemia | 1999-11 | PHASE2 |
| NCT00685061 | University of Miami | Renal Transplantation | 2002-11 | PHASE4 |
| NCT00070759 | National Eye Institute (NEI) | Uveitis | 2003-10-06 | PHASE2 |
| NCT00001865 | National Eye Institute (NEI) | Behcet´s Syndrome|Retinal Disease|Uveitis | 1999-07 | PHASE2 |
| NCT00859131 | Medical University of South Carolina|Genzyme, a Sanofi Company | End Stage Renal Disease | 2009-03 | NA |
| NCT00141037 | National Institute of Allergy and Infectious Diseases (NIAID)|Astellas Pharma Inc|Hoffmann-La Roche | Kidney Diseases|Kidney Transplantation|Kidney Transplant|Renal Transplantation|Renal Transplant | 2004-03 | PHASE1|PHASE2 |
| NCT00049725 | National Institutes of Health Clinical Center (CC) | Thrombocytopenia | 2002-11 | PHASE2 |
| NCT00080431 | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections | 2004-03-26 | PHASE1 |
| NCT00326508 | National Eye Institute (NEI) | Non-infectious Intermediate and Posterior Uveitis | 2006-05-11 | PHASE2 |
| NCT00682292 | University Hospital, Lille|Erasme University Hospital | Renal Transplantation | 2001-05 | PHASE3 |
| NCT00579527 | Sumitomo Pharma Switzerland GmbH|National Institutes of Health (NIH)|National Institute of Allergy and Infectious Diseases (NIAID)|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | DiGeorge Anomaly|Complete DiGeorge Anomaly|Complete Atypical DiGeorge Anomaly|Complete DiGeorge Syndrome|Complete Atypical DiGeorge Syndrome | 2005-12-19 | PHASE1|PHASE2 |
| NCT00231764 | Ekberg, Henrik, M.D.|Prof. Philip Halloran, Edmonton, Canada (sponsor)|Prof. Yves Vanrenterghem, Leuven, Belgium (Steering Committee Member)|Prof. Pierre Daloze, Montréal, Canada (Steering Committee Member)|Prof. Thomas C. Pearson, Atlanta, USA (Steering Committee Member)|Prof. Ulrich Frei, Berlin, Germany (Steering Committee Member)|Prof. Flavio Vincenti, San Francisco, USA (Ass. Steering Committee Member)|Prof. Josep Grinyo, Barcelona, Spain (Ass. Steering Committee Member)|Hoffmann-La Roche | Kidney Transplantation | 2002-11 | PHASE4 |
| NCT00246129 | EMagnusson | Kidney Transplantation|Kidney Diseases|Kidney Failure | 2005-10 | PHASE4 |
| NCT00078689 | National Eye Institute (NEI) | Uveitis | 2004-03-03 | PHASE1 |
| NCT02576145 | Hoffmann-La Roche | Kidney Transplantation | 2003-04 | PHASE4 |
| NCT00064714 | AstraZeneca|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Diabetes Mellitus | 2003-07 | PHASE2 |
| NCT00181142 | Johns Hopkins University | Patients Active and Listed for Lung Transplantation | 1999-10 | PHASE2|PHASE3 |
| NCT00198146 | Indiana University|Pescovitz, Mark D., M.D.|Roche Pharma AG|Facet Biotech | Newly Diagnosed With Type 1 Diabetes | 2000-07 | PHASE2 |
| NCT00048152 | Hoffmann-La Roche | Kidney Transplantation | 2000-12 | PHASE3 |
| NCT00001934 | National Institute of Neurological Disorders and Stroke (NINDS) | Multiple Sclerosis | 1999-09 | PHASE2 |